NCT07241715 2025-11-21
CONVERGENCE
National University Hospital, Singapore
Phase 2/3 Not yet recruiting
Clinical Trials
33 trialsNCT06826079 2025-09-09
SNCCTGC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2/3 Recruiting
NCT07000253 2025-06-02
OMEC-5
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase 2/3 Not yet recruiting
NCT06977061 2025-05-16
Efficacy and Safety of Fruquintinib Combined With Sintilimab and Stereotactic Body Radiation Therapy (SBRT) for the Second-line and Higher-line Treatment of Gastric or Gastroesophageal Junction Adenocarcinoma With Oligometastatic Progression
Second Affiliated Hospital of Nanchang University
Phase 2/3 Not yet recruiting
NCT06028737 2025-05-06
OCTASUR
Ukrainian Society of Clinical Oncology
Phase 2/3 Recruiting
NCT06782412 2025-02-07
FAPIDO
KU Leuven
Phase 2/3 Recruiting
NCT03607656 2023-12-18
CHANGE
Shanghai University of Traditional Chinese Medicine
Phase 2/3 Completed
NCT05325528 2023-02-01
Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases
Zhejiang University
Phase 2/3 Unknown
NCT05300945 2022-12-06
HIPEC Combined Gastrectomy in Patients With Advanced Gastric Cancer Received Neoadjuvant Chemotherapy
Tongji Hospital
Phase 2/3 Not yet recruiting
NCT02661971 2022-07-11
RAMSES/FLOT7
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2/3 Completed
NCT03130790 2022-02-15
Varlitinib in Combination With mFOLFOX6 for Advanced or Metastatic Gastric Cancer (First Line)
ASLAN Pharmaceuticals
Phase 2/3 Completed
NCT05002686 2021-08-24
Safety and Efficacy of Sintilimab in Combination With Chemoradiothrapy Followed by D2 Surgical Resection in Patients With Advanced Gastric Cancer With Retroperitoneal Lymph Node Metastasis
Ruijin Hospital
Phase 2/3 Unknown
NCT04393584 2021-04-13
RusGCG-01
Blokhin's Russian Cancer Research Center
Phase 2/3 Unknown
NCT04677673 2020-12-21
RJGC-Senile
Ruijin Hospital
Phase 2/3 Not yet recruiting
NCT02581462 2020-08-11
PETRARCA
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2/3 Completed
NCT01516944 2020-02-13
Perioperative Chemotherapy for Potentially Resectable Gastric Cancer
Hebei Medical University
Phase 2/3 Completed
NCT01216644 2019-06-19
5-FU, Leucovorin, Oxaliplatin and Docetaxel (FLOT) Versus Epirubicin, Cisplatin and 5-FU (ECF) in Patients With Locally Advanced, Resectable Gastric Cancer
Krankenhaus Nordwest
Phase 2/3 Completed
NCT01683864 2018-01-30
HIPECStomach
University Hospital Tuebingen
Phase 2/3 Terminated
NCT03399253 2018-01-16
Chemotherapy Alone Versus Surgery Plus Chemotherapy for Distal Gastric Cancer With One Non-curable Factor
Sun Yat-sen University
Phase 2/3 Unknown
NCT02509806 2017-10-09
Apatinib as Maintenance Therapy After First-line Chemotherapy(DC for 4 Cycles) in Postoperative Recurrence/Metastasis Progressive Gastric Cancer
Hebei Medical University
Phase 2/3 Unknown
NCT02510469 2017-10-09
Apatinib as Maintenance Therapy After Adjuvant Chemotherapy in Progressive Gastric Cancer With Positive Exfoliative Cancer Cells
Hebei Medical University
Phase 2/3 Unknown
NCT02817425 2016-06-29
A Efficacy and Tolerability Study of TEGAFOX Sequential S-1 in the Treatment of Adjuvant Chemotherapy for Gastric Cancer
LanZhou University
Phase 2/3 Unknown
NCT02409199 2015-11-18
A Study of Apatinib Versus Docetaxol Patients With Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Phase 2/3 Unknown
NCT02413476 2015-05-19
Comparison of Surgical,Clinical and Oncological Outcomes Between Robotic-assisted and Laparoscopic-assisted Gastrectomy
Chinese PLA General Hospital
Phase 2/3 Unknown
NCT02442362 2015-05-13
TOF Versus SOX in Metastatic Gastric Cancer
The First People's Hospital of Changzhou
Phase 2/3 Completed
NCT02423278 2015-04-22
The Long-term Effect of D4 Lymphadenectomy for Gastric Cancer
First Affiliated Hospital, Sun Yat-Sen University
Phase 2/3 Unknown
NCT01787539 2013-02-08
STOPEROPCHEM
Medical University of Lublin
Phase 2/3 Unknown
NCT01655641 2012-10-16
TMGS
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Phase 2/3 Unknown
NCT01528059 2012-02-07
Roux-en-Y Versus Billroth II Reconstruction After Subtotal Gastrectomy in Gastric Cancer Comorbid With Type II Diabetes
Xiamen University
Phase 2/3 Unknown
NCT00970138 2011-07-12
Apatinib Versus Placebo as a Third Line Treatment in Patients With Advanced or Metastatic Gastric Cancer
Fudan University
Phase 2/3 Completed
NCT00639327 2011-06-28
Second Line Chemotherapy for S-1 Refractory Advanced Gastric Cancer
Japan Clinical Cancer Research Organization
Phase 2/3 Completed
NCT01206218 2010-09-21
BREC-AGC
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 2/3 Unknown
NCT00503321 2009-01-23
eNCIT-Japan
Eastern Network of Cancer Immunological Therapy, Japan
Phase 2/3 Terminated